» Authors » Sandra E Ghayad

Sandra E Ghayad

Explore the profile of Sandra E Ghayad including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 29
Citations 856
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Ramadan F, Saab R, Ghamloush F, Khoueiry R, Herceg Z, Gomez L, et al.
Cancers (Basel) . 2024 May; 16(9). PMID: 38730605
Rhabdomyosarcoma is a pediatric cancer associated with aggressiveness and a tendency to develop metastases. Fusion-negative rhabdomyosarcoma (FN-RMS) is the most commonly occurring subtype of RMS, where metastatic disease can hinder...
2.
Rammal G, Fahs A, Kobeissy F, Mechref Y, Zhao J, Zhu R, et al.
J Proteome Res . 2023 Sep; 22(11):3660-3661. PMID: 37769164
No abstract available.
3.
Ayoub A, El-Achkar G, Ghayad S, Hariss L, Haidar R, Antar L, et al.
Int J Mol Sci . 2023 Jun; 24(12). PMID: 37373544
Benzofuran and 2,3-dihydrobenzofuran scaffolds are heterocycles of high value in medicinal chemistry and drug synthesis. Targeting inflammation in cancer associated with chronic inflammation is a promising therapy. In the present...
4.
Albaret M, Textoris J, Dalzon B, Lambert J, Linard M, Helmer C, et al.
Transl Psychiatry . 2023 Mar; 13(1):86. PMID: 36898995
Many studies highlight the potential link between the chronic degenerative Alzheimer's disease and the infection by the herpes simplex virus type-1 (HSV-1). However, the molecular mechanisms making possible this HSV-1-dependent...
5.
Fahme P, Ramadan F, Le D, Nguyen Thi K, Ghayad S, Hussein N, et al.
Cancers (Basel) . 2022 Dec; 14(24). PMID: 36551531
The oncogenic transcription factor ZNF217 orchestrates several molecular signaling networks to reprogram integrated circuits governing hallmark capabilities within cancer cells. High levels of ZNF217 expression provide advantages to a specific...
6.
Ramadan F, Saab R, Hussein N, Clezardin P, Cohen P, Ghayad S
Front Oncol . 2022 Aug; 12:971174. PMID: 36033507
Rhabdomyosarcoma (RMS) is a soft tissue sarcoma of skeletal muscle differentiation, with a predominant occurrence in children and adolescents. One of the major challenges facing treatment success is the presence...
7.
Fahs A, Hussein N, Zalzali H, Ramadan F, Ghamloush F, Tamim H, et al.
Cells . 2022 Jul; 11(15). PMID: 35892564
Rhabdomyosarcoma (RMS) is an aggressive childhood soft-tissue tumor, with propensity for local invasion and distant metastasis. Exosomes are secreted vesicles that mediate paracrine signaling by delivering functional proteins and miRNA...
8.
Fahs A, Ramadan F, Ghamloush F, Ayoub A, Ali Ahmad F, Kobeissy F, et al.
Front Oncol . 2020 Oct; 10:1784. PMID: 33117671
Rhabdomyosarcoma (RMS) is a highly malignant soft tissue sarcoma classified into two major histologic subtypes: embryonal (ERMS) and alveolar (ARMS). ARMS subtype is clinically more aggressive, and characterized by an...
9.
Donini C, El Helou M, Wierinckx A, Gyorffy B, Aires S, Escande A, et al.
Front Oncol . 2020 Jul; 10:712. PMID: 32670863
It is of utmost importance to decipher the role of chronic exposure to low doses of environmental carcinogens on breast cancer progression. The early-transformed triple-negative human mammary MCF10AT1 cells were...
10.
Farhat D, Ghayad S, Icard P, Le Romancer M, Hussein N, Lincet H
Oncogene . 2020 Feb; 39(17):3604-3610. PMID: 32060422
The beneficial effects of lipoic acid (LA) in cancer treatment have been well documented in the last decade. Indeed, LA exerts crucial antiproliferative effects by reducing breast cancer cell viability,...